PrecisionLife is attending BIO Europe Spring 2023 to discuss strategic R&D collaboration partnerships with biopharma companies innovating to develop better treatments for chronic disease.
Meet with our partnering representatives attending BIO Europe:
We have a range of strategic R&D collaboration options to discuss potential partnership - from licensable novel target and discovery projects, to identification of patient stratification biomarkers for enriching clinical trials design around existing target programs, and retrospective analysis of clinical trial data to identify biomarkers of drug response, through to the identification of secondary indication potential for your development programs.
Our scalable platform has delivered the deepest disease insights in over 45 complex, chronic indications, and a valuable pipeline of drug discovery IP in the form of novel drug targets and precision drug repositioning opportunities for multiple conditions with compelling unmet medical needs. These insights are protected and derisked by our unique and highly specific mechanistic patient stratification biomarkers.
Contact Georgia or Gianluca in the partneringONE platform or contact us to setup a meeting.